Antibodies
5 May 2014
FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access29 April 2014
Glenmark’s novel monoclonal antibody GBR 900 for treatment of chronic pain entering human trials25 April 2014
Daiichi Sankyo Announces Discontinuation of Phase 3 Clinical Trial in Japan of Nimotuzumab (DE-766) in Lung Cancer24 April 2014
FDA approves Sylvant for rare Castleman’s disease11 April 2014
PolyTherics and MacroGenics Extend Collaboration to Produce Novel Antibody Drug Conjugate11 April 2014
Precision Biologics’ NEO-102 Continues to Show Encouraging Results in Pancreatic and Colorectal Cancer PatientsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports